RIBON THERAPEUTICS
Ribon Therapeutics is a biotechnology company pioneering the discovery of new cancer medicines that target monoPARP proteins, critical regulators of cancer survival mechanisms. The diverse and central functions that PARPs, or poly(ADP-ribose) polymerases, play in cancer cell survival pathways are just emerging, and many of the seminal discoveries in the field have been made by Ribon’s scientific founders. By combining insights from our founders and an experienced management team, Ribon is bui... lding a proprietary drug discovery platform to investigate the molecular action and biological function of a subset of the PARP protein family, called monoPARPs. Based on its platform, Ribon is creating a pipeline of innovative medicines that selectively target monoPARPs to treat cancer and may have the potential to impact other diseases. The company is backed by prominent life science investors, including The Column Group, U.S. Venture Partners, Deerfield Management and Osage University Partners.
RIBON THERAPEUTICS
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.ribontx.com
Total Employee:
11+
Status:
Active
Contact:
617-914-8700
Email Addresses:
[email protected]
Total Funding:
184 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Domain Not Resolving Sitelinks Search Box Euro
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Aerin Medical
Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.
AgeX Therapeutics
AgeX is a biotechnology company that develops novel therapeutics for age-related degenerative diseases.
Xilio Therapeutics
Xilio Therapeutics is a biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics.
Autifony Therapeutics
Autifony Therapeutics is a biotechnology company developing medicines to treat hearing disorders such as hearing loss and tinnitus.
Anchiano Therapeutics
Anchiano is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer.
CardioFocus
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.
Casma Therapeutics
Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.
Cellular Biomedicine Group
CBMG is a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancers and stem cell therapies.
Decibel Therapeutics
Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing.
Dianthus Therapeutics
Dianthus Therapeutics is a biotech company developer of therapeutics and drugs.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Egle Therapeutics
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Goldfinch Biopharma
Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.
GRO Biosciences
GRO Biosciences is a biotechnology company that expands the amino acid alphabet to overcome the limitations of protein therapeutics.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
IN8Bio
IN8Bio is a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer.
Lazurite
Lazurite is a biotechnology company that creates the operating room of the future through smart surgical tools.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
Jengu Therapeutics
Jengu Therapeutics is a biotech company focuses on cellular signaling pathways regulating normal cell proliferation and differentiation.
JOGO Health
JOGO Health is a biotech company focused on digital therepeutics for neuromuscular conditions.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
KinaRx
KinaRx is a biotech firm focuses on the development of novel kinase inhibitors for the treatment of Acute myeloid leukemia.
Noctrix Health
Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.
Northwest Biotherapeutics
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Ophidion
Ophidion is a biotechnology company that delivers a central nervous system therapeutics to targeted sites in the brain.
QED Therapeutics
QED Therapeutics is a biotechnology company focused on precision medicine for FGFR-driven disorders.
Relay Therapeutics
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
RenovoRx
RenovoRx is developing innovative solutions for targeted delivery of fluids to selected sites in the peripheral vascular system.
Aravive Biologics
Aravive Biologics is a clinical-stage biotechnology company that focuses on developing therapies that target important survival pathways.
Siolta Therapeutics
Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
SynerGene Therapeutics
SynerGene Therapeutics is a biotechnology company with focuses on developing gene-based nanotech cancer therapeutics and diagnostics.
Talaris Therapeutics
Talaris Therapeutics is a operator of a biotechnology company engaged in the development of innovative cellular therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
U.S. Venture Partners
U.S. Venture Partners investment in Series C - Ribon Therapeutics
GV
GV investment in Series C - Ribon Therapeutics
Peregrine Ventures
Peregrine Ventures investment in Series C - Ribon Therapeutics
Euclidean Capital
Euclidean Capital investment in Series C - Ribon Therapeutics
Bristol Myers Squibb
Bristol Myers Squibb investment in Series C - Ribon Therapeutics
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series C - Ribon Therapeutics
Deerfield
Deerfield investment in Series C - Ribon Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series C - Ribon Therapeutics
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series C - Ribon Therapeutics
The Column Group
The Column Group investment in Series C - Ribon Therapeutics
Official Site Inspections
http://www.ribontx.com Semrush global rank: 4.34 M Semrush visits lastest month: 2.62 K
- Host name: 104.26.4.187
- IP address: 104.26.4.187
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ribon Therapeutics"
Ribon Therapeutics - LinkedIn
Pioneering Therapeutics Targeting Cellular Stress Pathways | Ribon is a clinical-stage biotechnology company dedicated to the discovery and development of first-in-class small molecule inhibitors...See details»
Ribon Therapeutics - Crunchbase Company Profile
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways. View contacts for Ribon Therapeutics to access new leads and connect with decision-makers.See details»
Ribon Therapeutics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for RIBON THERAPEUTICS, INC. of Cambridge, MA.See details»
Ribon Therapeutics - PitchBook
Developer of a biopharmaceutical platform designed to block a cancer cell's fundamental ability to survive under stress. The company's platform provides the development of small molecule inhibitors or enzymes in the target family for …See details»
Ribon Therapeutics Information - RocketReach
Ribon Therapeutics is a Biotechnology Research, Business Services General, and Biotechnology company_reader located in Cambridge, Massachusetts with $43.5 million in revenue and 33 …See details»
Ribon Therapeutics Doses First Patient in Phase 1 ... - Business Wire
Mar 9, 2023 · Ribon Therapeutics is a clinical-stage biotechnology company developing therapeutics targeting novel enzyme families activated under cellular stress conditions that …See details»
Ribon Therapeutics, a Clinical Stage Biotechnology …
Feb 17, 2022 · Ribon, named a “Fierce 15” Biotech Company by Fierce Biotech in 2021, is pioneering the discovery and development of first-in-class precision therapies targeting stress support pathways in...See details»
Ribon Therapeutics - Overview, News & Similar companies
May 16, 2023 · View Ribon Therapeutics (www.ribontx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Ribon Therapeutics | VentureRadar
Website: http://www.ribontx.com/ Develops novel small molecules targeting stress support pathways in cancer and inflammation using proprietary BEACON+ platform, focusing on …See details»
Ribon Therapeutics - USVP/
Ribon Therapeutics discovers and develops novel small molecule therapeutics for major unmet medical needs. U.S. Venture Partners (USVP) is a leading Silicon Valley venture capital firm, partnering with entrepreneurs to transform their …See details»
Ribon Therapeutics Announces Presentations at the American …
Apr 11, 2022 · The AACR presentations are available on its corporate website via the following link: https://ribontx.com/publications/. About RBN-2397See details»
Ribon Therapeutics Announces $25 Million Equity Investment
Jan 30, 2023 · Ribon is located in Cambridge, Massachusetts. For more information, visit https://ribontx.com/. View source version on businesswire.com: …See details»
Ribon Therapeutics Initiates First-in-Human Phase 1 Clinical
Mar 22, 2022 · Ribon Therapeutics today announced that it initiated the healthy volunteer portion of its Phase 1, first-in-human, single ascending dose and multiple ascending dose (SAD/MAD) …See details»
Ribon Therapeutics Secures $65 Million Financing - Business Wire
Jul 14, 2021 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Ribon Therapeutics, a clinical stage biotechnology company developing therapeutics targeting stress support pathways in cancer …See details»
Ribon Therapeutics Presents Additional Preclinical Data on
Jun 22, 2020 · Presentations from Virtual Meeting I can be accessed at https://ribontx.com/events/. Ribon Therapeutics is a clinical stage biotechnology company …See details»
Ribon Therapeutics Announces License Agreement with Ono …
Feb 2, 2021 · Ribon Therapeutics, a clinical stage oncology company developing therapeutics targeting stress support pathways, today announced it has entered into an exclusive license …See details»
Ribon Therapeutics Initiates First-in-Human Phase 1 Clinical Study …
Mar 22, 2022 · RBN-3143 is a novel, orally administered, first-in-class inhibitor of PARP14 with potential as a therapy in a range of inflammatory diseases, with an initial focus in atopic …See details»
Ribon Therapeutics Announces License Agreement with Ono …
Feb 2, 2021 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--Ribon Therapeutics, a clinical stage oncology company developing therapeutics targeting stress support pathways, today …See details»
Ribon Therapeutics Announces Upcoming Presentation on RBN
Apr 29, 2021 · Ribon Therapeutics is a clinical stage biotechnology company developing therapeutics targeting novel enzyme families activated under cellular stress conditions that …See details»
Ribon Therapeutics Announces Upcoming Presentations at the …
Apr 6, 2021 · Following its AACR presentations, Ribon Therapeutics expects to make the poster presentations available on its corporate website via the following link: …See details»